IB 

Union Calendar No. 434 

114TH CONGRESS 

2D SESSION H. R. 4982 

[Report No. 114–560] 

To direct the Comptroller General of the United States to evaluate and 

report on the in-patient and outpatient treatment capacity, availability, 

and needs of the United States. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 18, 2016 

Mr. FOSTER (for himself and Mr. PALLONE) introduced the following bill; 

which was referred to the Committee on Energy and Commerce 

MAY 10, 2016 

Additional sponsors: Ms. HERRERA BEUTLER, Mr. ROKITA, Mr. KILMER, and 

Mr. TURNER

MAY 10, 2016 

Reported with an amendment, committed to the Committee of the Whole 

House on the State of the Union, and ordered to be printed 

[Strike out all after the enacting clause and insert the part printed in italic] 

[For text of introduced bill, see copy of bill as introduced on April 18, 2016] 


SSpencer on DSK4SPTVN1PROD with BILLS
2 

•HR 4982 RH

A BILL 

To direct the Comptroller General of the United States to 

evaluate and report on the in-patient and outpatient 

treatment capacity, availability, and needs of the United 

States. 


SSpencer on DSK4SPTVN1PROD with BILLS
3 

•HR 4982 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Examining Opioid 

5 Treatment Infrastructure Act of 2016’’. 

6 SEC. 2. STUDY ON TREATMENT INFRASTRUCTURE. 

7 Not later than 24 months after the date of enactment 

8 of this Act, the Comptroller General of the United States 

9 shall initiate an evaluation, and submit to Congress a re10 port, of the inpatient and outpatient treatment capacity, 

11 availability, and needs of the United States, which shall 

12 include, to the extent data are available— 

13 (1) the capacity of acute residential or inpatient 

14 detoxification programs; 

15 (2) the capacity of inpatient clinical stabiliza16 tion programs, transitional residential support serv17 ices, and residential rehabilitation programs; 

18 (3) the capacity of demographic specific residen19 tial or inpatient treatment programs, such as those 

20 designed for pregnant women or adolescents; 

21 (4) geographical differences of the availability of 

22 residential and outpatient treatment and recovery op23 tions for substance use disorders across the continuum 

24 of care; 


SSpencer on DSK4SPTVN1PROD with BILLS
4 

•HR 4982 RH

1 (5) the availability of residential and outpatient 

2 treatment programs that offer treatment options based 

3 on reliable scientific evidence of efficacy for the treat4 ment of substance use disorders, including the use of 

5 Food and Drug Administration-approved medicines 

6 and evidence-based nonpharmacological therapies; 

7 (6) the number of patients in residential and 

8 specialty outpatient treatment services for substance 

9 use disorders; 

10 (7) an assessment of the need for residential and 

11 outpatient treatment for substance use disorders 

12 across the continuum of care; 

13 (8) the availability of residential and outpatient 

14 treatment programs to American Indians and Alaska 

15 Natives through an Indian health program (as de16 fined by section 4 of the Indian Health Care Improve17 ment Act (25 U.S.C. 1603)); and 

18 (9) the barriers (including technological barriers) 

19 at the Federal, State, and local levels to real-time re20 porting of de-identified information on drug overdoses 

21 and ways to overcome such barriers. 


SSpencer on DSK4SPTVN1PROD with BILLS

SSpencer on DSK4SPTVN1PROD with BILLS
Union Calendar No. 434 

114TH CONGRESS 

2D SESSION H. R. 4982 

[Report No. 114–560] 

A BILL 

To direct the Comptroller General of the United 

and needs of the United States. and outpatient treatment capacity, availability, States to evaluate and report on the in-patient 

MAY 10, 2016 

Reported with an amendment, committed to the Comand ordered to be printed mittee of the Whole House on the State of the Union, 


SSpencer on DSK4SPTVN1PROD with BILLS